Douglas V Faget

7PUBLICATIONS
59CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 21, 2026
Targeting CD24 activates macrophages to reduce tumor burden in preclinical models of solid tumors.

|Dec 30, 2025
Chemotherapy-induced adipo-lineage cell senescence drives bone loss.

Ganesh Kumar Raut, Taylor Malachowski, Anupama Melam

|Apr 29, 2024
Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression.

Jiayu Ye, John M Baer, Douglas V Faget

|Mar 08, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy.

Douglas V Faget, Xianmin Luo, Matthew J Inkman

|Jan 15, 2020
Therapy-Induced Senescence Drives Bone Loss.

Zhangting Yao, Bhavna Murali, Qihao Ren

|Jun 26, 2019
Unmasking senescence: context-dependent effects of SASP in cancer.

Douglas V Faget, Qihao Ren, Sheila A Stewart

Pageof 2

Frequent Collaborators

4 joint publications

Sheila A Stewart

3 joint publications

Qihao Ren

3 joint publications

David G DeNardo

2 joint publications

Xianmin Luo